| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $2.3M | +182.9% |
| SG&A Expense | $5.1M | -0.0% |
| Operating Income | -$8.5M | +40.2% |
| Pre-tax Income | -$186.9M | -1220.8% |
| Income Tax | -$55K | -71.3% |
| Net Income | -$186.9M | -1250.6% |
| EPS (Basic) | -$6.16 | -324.8% |
| EPS (Diluted) | -$6.16 | -324.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $456K | +1923.4% |
| Current Assets | $829K | +2513.8% |
| Total Assets | $670.2M | — |
| Current Liabilities | $1.2M | -17.6% |
| Total Liabilities | $2.0M | -26.2% |
| Stockholders' Equity | $667.9M | — |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.8M | -20.5% |
| Investing Cash Flow | -$650K | +0.0% |
| Financing Cash Flow | $7.3M | +516.8% |